vy /agouti (A vy) mice have late onset obesity related to overexpression of agouti signaling protein (ASP) in the hypothalamus. As mahogany modulates the actions of ASP, we tested the transport of mahogany peptide across the blood-brain barrier (BBB). The brain uptake of mahogany peptide was significantly higher in young A vy mice, and it preceded the surge of fat mass quantified by nuclear magnetic resonance. The results suggest a role of accelerated BBB transport in the epigenetics of A vy mice.
Introduction
The viable yellow A vy /agouti (A vy ) mouse results from a mutation leading to ectopic expression of agouti protein in all somatic cells. The genetic mutation involves insertion of a retrovirus-like repetitive intracisternal-A particle (IAP) into a noncoding exon of agouti, which results in fusion of the constitutively active Raly promoter to the agouti gene. This IAP element leads to ectopic overexpression of a 131 aminoacid agouti signaling protein (ASP) in the hypothalamus that acts as a melanocortin 4-receptor antagonist similar to agouti-related peptide (AgRP). The final outcome is hyperphagia and obesity. 1, 2 The A vy mouse differs from other genetically obese mouse strains, including the A y mouse that results from a large deletion affecting several contiguous genes. Unusually, obesity in the A vy mouse occurs only after puberty, and the increased fat mass is explained by hypertrophy (cell size) rather than hyperplasia (cell number) of the adipocytes. [3] [4] [5] Further, the obesity phenotype in A vy mice can be modified perinatally. Dolinoy et al. 6 showed that genistein, an isoflavone abundant in soy products which inhibits protein phosphorylation, can change coat color and reduce the percentage of obese offspring when provided to pregnant A vy mice. This exemplifies dynamic reprogramming of DNA methylation in A vy mice. 7 Studies of the epigenetically sensitive allele indicate the ongoing interactions between the peripheral circulation and the CNS in feeding behavior, part of which is mediated by the blood-brain barrier (BBB). The action of ASP is modulated by the mahogany/atractin gene. 8, 9 Its mutation (Atrn mg ) suppresses the effects of overexpression of ASP, so that mahogany protects against obesity in several situations. 10, 11 The mahogany gene produces a 1428 amino-acid protein, with a C-terminal peptide conserved from Caenorhabditis elegans to the mouse and human, that is expressed both in the periphery and hypothalamus. 12 The 1377-1428 terminus of the mahogany peptide crosses the BBB by a saturable transport system, 13 in contrast to AgRP 83F132 , which crosses poorly. 14 Here, we examine the possibility that transport of the mahogany peptide across the BBB may play a modulatory role in the obesity of A vy mice.
Materials and methods

Mice
The animal procotol was approved by the Institutional Animal Care and Use Committee. B6 and A vy mice were kindly provided in our institution by Dr George Bray who originally obtained the breeding colony from Jackson Laboratory (Bar Harbor, ME, USA). They were kept on a light-dark cycle of 0700-1900 and fed a regular diet. I by the chloramine-T method and purified by elution on a column of Sephadex G-10. The specific activity was 30 Ci/g, and acid precipitation showed 99% incorporation of the label. To determine the brain uptake of [ 125 I]-mahogany 1377-1428 , mice between 1 month and 1 year old (n ¼ 2-5/group) were anesthetized with ketamine/ xylazine and injected intravenously with the radioactively labeled peptide at time 0. At 10 min, blood and brain were collected and the brain/serum ratio of radioactivity was calculated and represented as ml/g ((c.p.m./g of brain)/ (c.p.m./ml of serum)). Group means are presented with their standard errors, and the significant difference between groups was determined by one-way analysis of variance followed by post hoc comparisons. The results were replicated with different batches of mice and the representative findings shown. Figure 1, than in all the other groups of mice studied at the same time ( Figure 2 ). This pattern was not seen in peripheral organs, including the kidney, lungs, liver and spleen.
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Discussion
Yellow A vy mice develop late-onset obesity resembling the human metabolic syndrome. 15 Their increased fat mass was clearly demonstrated by NMR, which is more precise and rapid than other methods of assessing body composition, Figure 1 (a) Fat mass determined by NMR in A vy mice and their B6 controls at 1, 7 and 12 months of age. Fat mass was significantly greater in the 7 than the 12-month-old mice in both strains. By contrast to the decreasing fat mass in the old B6 mice, the old A vy mice had a dramatic surge of fat mass at 12 months of age. *Po0.05; **Po0.01; ***Po0.005 compared with the corresponding 1-month-old groups. (b) There was a significant (Po0.01) linear regression correlation between body weight and fat mass in all groups of mice. Mahogany, blood-brain barrier, and fat mass surge in AVY mice W Pan and AJ Kastin including dual energy X-ray absorptiometry, chemical analysis, plethysmography, hydrostatic weighing, bioelectrical impedance and electrical conductivity. 16 Weight gain correlated with increased fat mass; these increases were agedependent, not evident until the A vy mice were more than 7 months old. This raises intriguing questions about modulatory factors superimposed upon genetic predisposition, pointing to potential therapeutic influences on the epigenetics of hyperphagia and obesity. We have shown that mahogany peptide uses a saturable transport system to cross the BBB in intact form and reaches the brain parenchyma. The rate of influx in the ICR mice of that study was similar to the influx found in all but one group of A vy and B6 mice in the present study. The exceptional group consisted of the young A vy mice, which had the most rapid BBB penetration by the mahogany peptide. This fast influx was no longer evident in either of the older groups of A vy mice or in any of the B6 controls; it preceded the striking increase of fat mass quantified in the 1-year-old mice. This raises the possibility that enhanced brain uptake of mahogany peptide at an early age may protect against obesity. Levin et al. 17 have shown another unusual situation involving the BBB in rats bred to be sensitive to diet-induced obesity. Only at a later age (23 weeks) did the permeation of leptin decrease significantly in these rats, lagging behind their obesity phenotype (seen by 11 weeks of age), as well as leptin receptor expression and signaling by the phosphorylated signal transducer and activator of transcription 3 (both reduced at 4-5 weeks of age). By contrast, in our studies with A vy mice, the reduction of BBB transport of mahogany preceded manifestation of the obesity phenotype, supporting the role of the BBB as a cause, rather than a consequence, of adult-onset obesity in the A vy mice.
In summary, we showed a temporal relationship suggesting that the reduction of mahogany transport might contribute to the late-onset type of obesity characteristic of A vy mice. The dynamic changes of mahagony transport in the A vy mice indicate that the BBB can play an early role in communicating peripheral obese signals to the brain preceding obesity.
